Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2024 Annual Meeting | C96 - Endovascular Management of Ischemic and Hemorrhagic Stroke

Monday 04/15/24
03:30 PM - 05:30 PM MDT Add To Calendar
Colorado Convention Center | Mile High 4CD
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Johanna Therese Fifi, MD, FAAN
Cerebrovascular Disease and Interventional Neurology
Through partly didactic and partly case-based discussion, participants should become familiar with new trials providing evidence for expanded thrombectomy indications, advances in organization of stroke systems of care and trials exploring new workflow and advances in the management of ruptured aneurysms and hemorrhagic stroke. New indications including large core, distal occlusions, and low NIHSS will be explored, and direct to angio and EMS triage will be discussed.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Systems-based Practice
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:35 PM MDT Introduction Introduction to Endovascular Management of Ischemic and Hemorrhagic Stroke
Johanna Therese Fifi, MD, FAAN
03:35 PM - 04:05 PM MDT Speaker Update in Endovascular Stroke Therapy: Breaking Barriers
Hazem M. Shoirah, MD
04:05 PM - 04:35 PM MDT Speaker New Trends in Endovascular Management of Ruptured Aneurysms
Jenny Peih-Chir Tsai, MD
04:35 PM - 05:10 PM MDT Speaker Advances in Hemorrhagic Stroke: Embo for SDH and ICH Evacuation
Christopher Paul Kellner, MD
05:10 PM - 05:30 PM MDT Q&A Questions & Answers
Johanna Therese Fifi, MD, FAAN, Jenny Peih-Chir Tsai, MD, Hazem M. Shoirah, MD, Christopher Paul Kellner, MD
Faculty Disclosures
Johanna Therese Fifi, MD, FAAN Dr. Fifi has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Stryker, Inc. Dr. Fifi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Microvention. Dr. Fifi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Fifi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Fifi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Serenity. Dr. Fifi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MIVI. Dr. Fifi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. Dr. Fifi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. Dr. Fifi has stock in Endostream. Dr. Fifi has stock in Synchron. Dr. Fifi has stock in Imperative Care. Dr. Fifi has stock in Truvic. Dr. Fifi has stock in Bendit. Dr. Fifi has stock in Cerebrotech. Dr. Fifi has stock in Sim&Cure. Dr. Fifi has stock in Q'Apel. The institution of Dr. Fifi has received research support from Viz AI.
Hazem M. Shoirah, MD Dr. Shoirah has nothing to disclose.
Christopher Paul Kellner, MD Dr. Kellner has stock in METIS Innovative. Dr. Kellner has stock in Precision Recovery. Dr. Kellner has stock in Synchron. Dr. Kellner has stock in Fluid BioMed. Dr. Kellner has stock in Proprio. Dr. Kellner has stock in Von Vascular. Dr. Kellner has stock in E8. Dr. Kellner has stock in Borvo. Dr. Kellner has stock in Phantom Neuro. The institution of Dr. Kellner has received research support from Integra. The institution of Dr. Kellner has received research support from Penumbra. The institution of Dr. Kellner has received research support from Viz.AI. The institution of Dr. Kellner has received research support from ICE Neurosystems. The institution of Dr. Kellner has received research support from Irras. The institution of Dr. Kellner has received research support from Microtransponder. The institution of Dr. Kellner has received research support from Medtronic. The institution of Dr. Kellner has received research support from Longeviti. The institution of Dr. Kellner has received research support from Endostream. The institution of Dr. Kellner has received research support from CVAID.
Jenny Peih-Chir Tsai, MD Dr. Tsai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Tsai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Microvention. Dr. Tsai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Tsai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Q'Apel. Dr. Tsai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imperative Care. Dr. Tsai has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Society of NeuroInterventional Surgery.